Effects of salt loading and various therapies on cardiac hypertrophy and fibrosis in young spontaneously hypertensive rats

Life Sciences
Barbara Ziegelhöffer-MihalovicovaBeate Rassler

Abstract

We investigated the effects of salt loading on blood pressure, cardiac hypertrophy and fibrosis as well as on the effectiveness of various antihypertensive therapies in young spontaneously hypertensive rats (SHR). Twenty-five male SHR were salt-stimulated by drinking 1% NaCl from 3 to 6 months of age. Eighteen of them were treated for the last 2 weeks of salt loading with either the angiotensin-converting enzyme inhibitor captopril, the beta-adrenergic receptor blocker propranolol or the calcium-channel antagonist verapamil. Age-matched male Wistar-Kyoto (WKY) rats and SHR drinking only water served as controls. At the age of 6 months, SHR had significantly elevated blood pressure that was unchanged by salt loading. Relative heart weight was increased in SHR without (3.3) and even more so with salt intake (3.6 vs. 2.4 in WKY). Left ventricular (LV) hypertrophy was accompanied by a 17-fold increase in the expression of mRNA for atrial natriuretic factor (ANF) both in untreated and salt-loaded SHR compared to WKY (p<0.001). Collagen I and III mRNA increased 1.7-1.8-fold in SHR without and with additional salt intake (p<0.01). None of the therapies significantly reduced blood pressure or hypertrophy. Although captopril had no anti...Continue Reading

References

Sep 1, 1992·European Heart Journal·C G BrillaK T Weber
Jul 1, 1991·Naunyn-Schmiedeberg's Archives of Pharmacology·T K Keeton, A M Biediger
Jan 1, 1986·Journal of Cardiovascular Pharmacology·D G McDevitt
Jan 1, 1989·Clinical and Experimental Hypertension. Part A, Theory and Practice·W LinzD Ganten
Jan 1, 1986·Clinical and Experimental Hypertension. Part A, Theory and Practice·Y TakataM Fujishima
May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·J M PfefferE Braunwald
Jan 1, 1984·Drug Metabolism Reviews·B H MigdalofK J Kripalani
Nov 1, 1994·British Journal of Pharmacology·H BouazizA Benetos
Dec 14, 2002·Basic Research in Cardiology·Konrad F FrankRobert H G Schwinger
Apr 23, 2003·Respiratory Physiology & Neurobiology·Beate RasslerHeinz Gerd Zimmer
Apr 9, 2004·The Journal of Clinical Endocrinology and Metabolism·Cristina PalaciosConnie M Weaver
Jun 24, 2004·Circulation·Veronica FrancoOscar A Carretero
Jul 1, 2004·Circulation·Veronica FrancoOscar A Carretero
Mar 25, 2005·Molecular and Cellular Biochemistry·Mazen KurdiGiampiero Bricca

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.